Reductions in sample pretreatment requirements by using high-performance capillary electrokinetic separation methods.
Altria
K D
KD
Pharmaceutical Analysis Division, Glaxo Group Research, Ware, Herts, UK.
Rogan
M M
MM
D002444:Cefuroxime / Q000031:analogs & derivatives / Q000032:analysis; D002845:Chromatography / Q000379:methods*; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D007202:Indicators and Reagents; D011899:Ranitidine / Q000032:analysis; D013056:Spectrophotometry, Ultraviolet
D007202:Indicators and Reagents; D011899:Ranitidine; D002444:Cefuroxime; C040738:cefuroxime axetil